Viemed Healthcare, Inc. financial data

Symbol
VMD on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
625 E. Kaliste Saloom Rd., Lafayette, LA
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 130 % -13.2%
Quick Ratio 13.6 % -11.3%
Debt-to-equity 34.8 % +10.1%
Return On Equity 8.72 % -2.79%
Return On Assets 6.48 % -4.84%
Operating Margin 7.81 % +5.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.9M shares +1.16%
Common Stock, Shares, Outstanding 38.9M shares +1.15%
Entity Public Float 330M USD +81.2%
Common Stock, Value, Issued 22.7M USD +22.1%
Weighted Average Number of Shares Outstanding, Basic 38.9M shares +1.13%
Weighted Average Number of Shares Outstanding, Diluted 40.8M shares +0.89%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 214M USD +26.2%
Research and Development Expense 2.92M USD +2.21%
Operating Income (Loss) 16.7M USD +33.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 14.9M USD +15.8%
Income Tax Expense (Benefit) 4.48M USD +21.2%
Net Income (Loss) Attributable to Parent 10.4M USD +13.3%
Earnings Per Share, Basic 0.27 USD/shares +8%
Earnings Per Share, Diluted 0.26 USD/shares +8.33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 11.3M USD +12.6%
Accounts Receivable, after Allowance for Credit Loss, Current 27.1M USD +50.9%
Inventory, Net 4.31M USD -7.69%
Assets, Current 47.7M USD +33%
Deferred Income Tax Assets, Net 8.07M USD +106%
Property, Plant and Equipment, Net 74.4M USD +1.33%
Operating Lease, Right-of-Use Asset 2.76M USD +498%
Intangible Assets, Net (Excluding Goodwill) 880K USD +27.9%
Goodwill 33M USD +11.1%
Other Assets, Noncurrent 0 USD -100%
Assets 170M USD +13.5%
Employee-related Liabilities, Current 4.45M USD +31.1%
Accrued Liabilities, Current 19.9M USD +19.1%
Contract with Customer, Liability, Current 6.82M USD +9.72%
Liabilities, Current 36.4M USD +15.5%
Operating Lease, Liability, Noncurrent 1.99M USD +823%
Liabilities 42.7M USD +5.29%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) 85.4M USD +12.3%
Stockholders' Equity Attributable to Parent 125M USD +14.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 127M USD +16.5%
Liabilities and Equity 170M USD +13.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.18M USD -88.8%
Net Cash Provided by (Used in) Financing Activities -1.34M USD -3536%
Net Cash Provided by (Used in) Investing Activities -5.37M USD -37.4%
Common Stock, Shares, Issued 38.9M shares +1.15%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -5.53M USD -183%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 11.3M USD +12.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 224K USD +433%
Deferred Tax Assets, Valuation Allowance 19K USD -26.9%
Deferred Tax Assets, Gross 20.6M USD +11.9%
Operating Lease, Liability 2.73M USD
Depreciation 4.76M USD +40.2%
Payments to Acquire Property, Plant, and Equipment 6.01M USD +28.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 10.3M USD +69.6%
Lessee, Operating Lease, Liability, to be Paid 3.16M USD
Operating Lease, Liability, Current 742K USD +207%
Lessee, Operating Lease, Liability, to be Paid, Year Two 783K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 908K USD
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 436K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 667K USD
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 573K USD
Depreciation, Depletion and Amortization 6.29M USD +32%
Share-based Payment Arrangement, Expense 6.3M USD +11.8%